approved EB-2 (NIW) RFE Issued

Research Assistant (Ph.D. Candidate)

Microbiology · Egypt · 2025-07-17

Processing Time
395 days
Decision Date
2025-07-17
Location
Massachusetts
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research in microbiology focused on discovering antimicrobial agents and elucidating their mechanisms to combat multidrug-resistant bacteria. The work involves developing phage therapies, nanoparticle-drug hybrids, and innovative antimicrobial delivery systems to replace or augment conventional antibiotics. This endeavor aims to address the global healthcare emergency of antibiotic resistance and improve drug treatment efficacy.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses a global healthcare emergency regarding antibiotic resistance, which is a significant public health burden in the U.S.

2 Well-positioned to Advance the Endeavor Met

The petitioner's extensive publication record, high citation count, and funding from major organizations like STDF and BBSRC demonstrate they are well-positioned.

3 Waiver Benefit Met

On balance, it was found to be in the national interest to waive the job offer and labor certification requirements due to the critical nature of the research.

Why This Petition Was Approved

The petition was approved based on the petitioner's authorship of 35 peer-reviewed journal articles and one book chapter, which garnered 533 citations. The case demonstrated that 26 of these publications were among the most highly cited in the field, and the petitioner had performed 11 peer reviews for scholarly journals. The evidence satisfied all three prongs of the Dhanasar framework, highlighting the national importance of addressing multidrug-resistant infections.

Request for Evidence (RFE)

Successfully Addressed

An RFE was issued during the 13-month processing period; the legal team provided additional documentation to satisfy USCIS concerns, leading to a successful approval.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Research Assistant

Biotechnology · Bangladesh

WeGreened EB-2 (NIW) approved
Pennsylvania 109 days 2022-05-02
The petitioner proposes to continue her research in biomedical science, specifically focusing on advancing the understanding of mechanisms behind deadly diseases such as cholera, Salmonella, and COVID-19. Her work involves characterizing complex factors in antibiotic production and resistance to accelerate the development of novel, therapeutically effective antibiotics. The research aims to mitigate the threat of bacterial infections and minimize the prevalence and mortality of infectious diseases in the United States.

Research Scientist

Pharmaceuticals · China

WeGreened EB-2 (NIW) approved
Utah 52 days 2025-03-07
The petitioner proposes to design and develop novel antimicrobial compounds for in vitro and in vivo applications to combat resistant pathogens and bridge the gap between basic discovery and clinical translation.

Postdoctoral Researcher

Research and Development · Iran

WeGreened EB-2 (NIW) approved
7 days 2023-12-28
The petitioner proposes to continue research into microbiology, specifically focusing on elucidating bacteriophages’ bactericidal mechanisms and their beneficial interactions with the human gut microbiome. This work aims to advance the use of bacteriophages as novel therapeutics to develop effective strategies for combating antimicrobial resistance and modifying the gut microbiome.

Doctor

Healthcare · Lebanon

WeGreened EB-2 (NIW) approved
Florida 18 days 2025-03-01
The petitioner proposes to study the mechanisms and prevalence of antimicrobial resistance (AMR) and explore strategies to limit its spread. His work involves screening, vaccinating, and treating infections, monitoring antimicrobial susceptibilities, and conducting early detection of various medical conditions to address challenges in future pandemic-related health emergencies.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-07-17.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 395 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist